Pravastatin cost-effectiveness for primary prevention of cardiovascular disease in the US

被引：0
|
作者：
Hay, JW
Yuan, Y
Ford, I
McGuire, A
Shepherd, J
机构：
[1] UNIV GLASGOW,GLASGOW G12 8QQ,LANARK,SCOTLAND
[2] UNIV OXFORD,OXFORD OX1 2JD,ENGLAND
[3] UNIV GLASGOW,GLASGOW,LANARK,SCOTLAND
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1017 / 1017
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan
    Nagata-Kobayashi, S
    Shimbo, T
    Matsui, K
    Fukui, T
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 104 (02) : 213 - 223
  • [2] Primary prevention of cardiovascular disease: a cost-effectiveness comparison
    Franco, O
    De Laet, C
    Der Kinderen, A
    Peeters, A
    Bonneux, L
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [3] Primary prevention of cardiovascular disease: Cost-effectiveness comparison
    Franco, Oscar H.
    Kinderen, Arno J. der
    De Laet, Chris
    Peeters, Anna
    Bonneux, Luc
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 71 - 79
  • [4] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    [J]. CIRCULATION, 2004, 110 (17) : 802 - 802
  • [5] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [6] Cost-effectiveness of Pravastatin in secondary prevention of coronary artery disease
    Ashraf, T
    Hay, JW
    Pitt, B
    Wittels, E
    Crouse, J
    Davidson, M
    Furberg, CD
    Radican, L
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (04): : 409 - 414
  • [7] Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease
    Erickson, Kevin F.
    Japa, Sohan
    Owens, Douglas K.
    Chertow, Glenn M.
    Garber, Alan M.
    Goldhaber-Fiebert, Jeremy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1250 - 1258
  • [8] Smoking cessation for primary prevention of cardiovascular disease: A cost-effectiveness analysis
    Kinderen, AJD
    Oh, F
    De Laet, C
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 692 - 693
  • [9] COST-EFFECTIVENESS OF EICOSAPENTAENOIC ACID (EPA) ON PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
    Kodera, S.
    Kiyosue, A.
    Ando, J.
    Komuro, I
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A614 - A614
  • [10] The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
    van Gils, Paul F.
    Over, Eelco A. B.
    Hamberg-van Reenen, Heleen H.
    de Wit, G. Ardine
    van den Berg, Matthijs
    Schuit, Albertine J.
    Engelfriet, Peter M.
    [J]. BMJ OPEN, 2011, 1 (02):
12345